{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:42:03Z","timestamp":1771980123853,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100013057","name":"Innovation Scientists and Technicians Troop Construction Projects of Henan Province","doi-asserted-by":"crossref","award":["134200510021"],"award-info":[{"award-number":["134200510021"]}],"id":[{"id":"10.13039\/501100013057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13046-015-0265-z","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T13:10:38Z","timestamp":1449234638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-\u03baB activation in papillary thyroid carcinoma"],"prefix":"10.1186","volume":"34","author":[{"given":"Shuiying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,4]]},"reference":[{"issue":"5","key":"265_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60(5):277\u2013300.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"265_CR2","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.18632\/oncotarget.1830","volume":"5","author":"E Minna","year":"2014","unstructured":"Minna E, Romeo P, De Cecco L, Dugo M, Cassinelli G, Pilotti S, et al. miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget. 2014;5(9):2513\u201328.","journal-title":"Oncotarget"},{"key":"265_CR3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1089\/thy.2009.1603","volume":"19","author":"M Schlumberger","year":"2009","unstructured":"Schlumberger M, Sherman SI. Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advances. Thyroid. 2009;19:1393\u2013400.","journal-title":"Thyroid"},{"key":"265_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/era.12.8","volume":"12","author":"KL Kojic","year":"2012","unstructured":"Kojic KL, Kojic SL, Wiseman SM. Differentiated thyroid cancers: a comprehensive review of novel targeted therapies. Expert Rev Anticancer Ther. 2012;12:345\u201357.","journal-title":"Expert Rev Anticancer Ther"},{"key":"265_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1530\/EJE-11-0631","volume":"166","author":"M Schlumberger","year":"2012","unstructured":"Schlumberger M, Sherman SI. Approach to the patient with advanced differentiated thyroid cancer. Eur J Endocrinol. 2012;166:5\u201311.","journal-title":"Eur J Endocrinol"},{"key":"265_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569\u201380.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"265_CR7","first-page":"440","volume":"53","author":"A Greco","year":"2009","unstructured":"Greco A, Borrello MG, Miranda C, Degl\u2019Innocenti D, Pierotti MA. Molecular pathology of differentiated thyroid cancer. Q J Nucl Med Mol Imaging. 2009;53(5):440\u201353.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"265_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/CCO.0b013e3282f27e49","volume":"20","author":"D Shibru","year":"2008","unstructured":"Shibru D, Chung KW, Kebebew E. Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol. 2008;20:13\u20138.","journal-title":"Curr Opin Oncol"},{"key":"265_CR9","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1002\/cncr.26072","volume":"117","author":"A Mathur","year":"2011","unstructured":"Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O, et al. Higher rate of BRAF mutationin papillary thyroid cancer over time: a single-institution study. Cancer. 2011;117:4390\u20135.","journal-title":"Cancer"},{"key":"265_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.02289","volume":"155","author":"M Santoro","year":"2006","unstructured":"Santoro M, Melillo RM, Fusco A. RET\/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur J Endocrinol. 2006;155:645\u201353.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"265_CR11","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1210\/jc.2012-2926","volume":"98","author":"A Ferraro","year":"2013","unstructured":"Ferraro A, Schepis F, Leone V, Federico A, Borbone E, Pallante P, et al. Tumor suppressor role of the CL2\/DRO1\/CCDC80 gene in thyroid carcinogenesis. J Clin Endocrinol Metab. 2013;98(7):2834\u201343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"265_CR12","doi-asserted-by":"crossref","first-page":"E446","DOI":"10.1210\/jc.2012-3180","volume":"98","author":"R Rahbari","year":"2013","unstructured":"Rahbari R, Kitano M, Zhang L, Bommareddi S, Kebebew E. RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function. J Clin Endocrinol Metab. 2013;98(3):E446\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"265_CR13","doi-asserted-by":"crossref","first-page":"E1422","DOI":"10.1210\/jc.2013-1510","volume":"98","author":"PG Ziros","year":"2013","unstructured":"Ziros PG, Manolakou SD, Habeos IG, Lilis I, Chartoumpekis DV, Koika V, et al. Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells. J Clin Endocrinol Metab. 2013;98(8):E1422\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/ERC-12-0078","volume":"20","author":"D Degl\u2019Innocenti","year":"2013","unstructured":"Degl\u2019Innocenti D, Romeo P, Tarantino E, Sensi M, Cassinelli G, Catalano V, et al. DUSP6\/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Endocr Relat Cancer. 2013;20:23\u201337.","journal-title":"Endocr Relat Cancer"},{"key":"265_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.yexcr.2011.12.001","volume":"318","author":"P Peltomaki","year":"2012","unstructured":"Peltomaki P. Mutations and epimutations in the origin of cancer. Exp Cell Res. 2012;318:299\u2013310.","journal-title":"Exp Cell Res"},{"key":"265_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3835(99)00087-7","volume":"140","author":"K Nagasaki","year":"1999","unstructured":"Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T, Yamaguchi K, et al. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett. 1999;140:227\u201334.","journal-title":"Cancer Lett"},{"key":"265_CR17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1442-2050.2007.00759.x","volume":"21","author":"R Ogawa","year":"2008","unstructured":"Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, et al. Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis. Dis Esophagus. 2008;21:288\u201397.","journal-title":"Dis Esophagus"},{"key":"265_CR18","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1182\/blood-2010-09-304881","volume":"117","author":"H Duzkale","year":"2011","unstructured":"Duzkale H, Schweighofer CD, Coombes KR, Barron LL, Ferrajoli A, O\u2019Brien S, et al. LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients. Blood. 2011;117:4076\u201384.","journal-title":"Blood"},{"key":"265_CR19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.4173","volume":"230","author":"CH Lee","year":"2013","unstructured":"Lee CH, Wong TS, Chan JY, Lu SC, Lin P, Cheng AJ, et al. Epigenetic regulation of the X-linked tumor suppressors BEX1 and LDOC1 in oral squamous cell carcinoma. J Pathol. 2013;230:298\u2013309.","journal-title":"J Pathol"},{"issue":"4","key":"265_CR20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ijc.11122","volume":"105","author":"K Nagasaki","year":"2003","unstructured":"Nagasaki K, Schem C, von Kaisenberg C, Biallek M, R\u00f6sel F, Jonat W, et al. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer. 2003;105(4):454\u20138.","journal-title":"Int J Cancer"},{"issue":"6","key":"265_CR21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MPG.0b013e3182a7e1da","volume":"57","author":"Z Song","year":"2013","unstructured":"Song Z, Dong R, Zhao R, Zheng S. Overexpression of LDOC1 in human biliary epithelial cells inhibits apoptosis through NF-\u03baB signaling. J Pediatr Gastroenterol Nutr. 2013;57(6):713\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"265_CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol. 2011;12:695\u2013708.","journal-title":"Nat Immunol"},{"key":"265_CR23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/ERC-11-0076","volume":"18","author":"A Bommarito","year":"2011","unstructured":"Bommarito A, Richiusa P, Carissimi E, Pizzolanti G, Rodolico V, Zito G, et al. BRAFV600E mutation, TIMP-1 upregulation, and NF-kappaB activation: closing the loop on the papillary thyroid cancer trilogy. Endocr Relat Cancer. 2011;18:669\u201385.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"265_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/thy.2012.0237","volume":"23","author":"X Li","year":"2012","unstructured":"Li X, Abdel-Mageed AB, Mondal D, Kandil E. The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers. Thyroid. 2012;23(2):209\u201318.","journal-title":"Thyroid"},{"key":"265_CR25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jso.22113","volume":"105","author":"A Wunderlich","year":"2012","unstructured":"Wunderlich A, Arndt T, Fischer M, Roth S, Ramaswamy A, Greene BH, et al. Targeting the proteasome as a promising therapeutic strategy in thyroid cancer. J Surg Oncol. 2012;105:357\u201364.","journal-title":"J Surg Oncol"},{"issue":"1","key":"265_CR26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2014.06.012","volume":"97","author":"W Zeng","year":"2014","unstructured":"Zeng W, Chang H, Ma M, Li Y. CCL20\/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production. Exp Mol Pathol. 2014;97(1):184\u201390.","journal-title":"Exp Mol Pathol"},{"key":"265_CR27","first-page":"259","volume":"69","author":"A Follenzi","year":"2002","unstructured":"Follenzi A, Naldini L. HIV-based vectors, preparation and use. Methods Mol Med. 2002;69:259\u201374.","journal-title":"Methods Mol Med"},{"issue":"5\u20136","key":"265_CR28","first-page":"313","volume":"23","author":"B Blits","year":"2005","unstructured":"Blits B, Kitay BM, Farahvar A, Caperton CV, Dietrich WD, Bunge MB. Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci. 2005;23(5\u20136):313\u201324.","journal-title":"Restor Neurol Neurosci"},{"key":"265_CR29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0076-6879(02)46071-5","volume":"346","author":"A Follenzi","year":"2002","unstructured":"Follenzi A, Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol. 2002;346:454\u201365.","journal-title":"Methods Enzymol"},{"issue":"3","key":"265_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng1117","volume":"33","author":"DA Rubinson","year":"2003","unstructured":"Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003;33(3):401\u20136.","journal-title":"Nat Genet"},{"key":"265_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","volume":"452","author":"C Pinheiro","year":"2008","unstructured":"Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, et al. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch. 2008;452:139\u201346.","journal-title":"Virchows Arch"},{"issue":"4","key":"265_CR32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","volume":"223","author":"SB Ng","year":"2011","unstructured":"Ng SB, Selvarajan V, Huang G, Zhou J, Feldman AL, Law M, et al. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling. J Pathol. 2011;223(4):496\u2013510.","journal-title":"J Pathol"},{"key":"265_CR33","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2008-1102","volume":"93","author":"RE Schweppe","year":"2008","unstructured":"Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, et al. DNA profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008;93:4331\u2013441.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"265_CR34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/ijc.24068","volume":"124","author":"JU Ammann","year":"2009","unstructured":"Ammann JU, Haag C, Kasperczyk H, Debatin KM, Fulda S. Sensitization of neuroblastoma cells for TRAIL induced apoptosis by NF-kappaB inhibition. Int J Cancer. 2009;124(6):1301\u201311.","journal-title":"Int J Cancer"},{"issue":"2","key":"265_CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1067\/msy.2001.115512","volume":"130","author":"CB Weldon","year":"2001","unstructured":"Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001;130(2):143\u201350.","journal-title":"Surgery"},{"issue":"49","key":"265_CR36","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1038\/sj.onc.1207029","volume":"22","author":"SB Bravo","year":"2003","unstructured":"Bravo SB, Pamp\u00edn S, Cameselle-Teijeiro J, Carneiro C, Dom\u00ednguez F, Barreiro F, et al. TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation. Oncogene. 2003;22(49):7819\u201330.","journal-title":"Oncogene"},{"issue":"3","key":"265_CR37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4239","volume":"231","author":"GT Chung","year":"2013","unstructured":"Chung GT, Lou WP, Chow C, To KF, Choy KW, Leung AW, et al. Constitutive activation of distinct NF-\u03baB signals in EBV-associated nasopharyngeal carcinoma. J Pathol. 2013;231(3):311\u201322.","journal-title":"J Pathol"},{"issue":"7092","key":"265_CR38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431\u20136.","journal-title":"Nature"},{"issue":"1","key":"265_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cell.2006.09.019","volume":"127","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, Balkwill F. RalB signaling: a bridge between inflammation and cancer. Cell. 2006;127(1):42\u20134.","journal-title":"Cell"},{"key":"265_CR40","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1158\/0008-5472.CAN-10-0732","volume":"70","author":"M Liu","year":"2010","unstructured":"Liu M, Sakamaki T, Casimiro MC, Willmarth NE, Quong AA, Ju X, et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 2010;70:10464\u201373.","journal-title":"Cancer Res"},{"key":"265_CR41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13046-015-0132-y","volume":"34","author":"H Zhang","year":"2015","unstructured":"Zhang H, Teng X, Liu Z, Zhang L, Liu Z. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. J Exp Clin Cancer Res. 2015;34:16.","journal-title":"J Exp Clin Cancer Res"},{"key":"265_CR42","first-page":"1531","volume":"28","author":"V Ellenrieder","year":"2008","unstructured":"Ellenrieder V. TGF beta regulated gene expression by Smads and Sp1\/KLF-like transcription factors in cancer. Anticancer Res. 2008;28:1531\u20139.","journal-title":"Anticancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0265-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:20:56Z","timestamp":1589606456000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-015-0265-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1186\/s13046-015-0265-z","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"146"}}